Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 28,624 | 19,355 | 17,755 | 1,936 | 66,769 |
| Cost of Goods | 5,592 | 2,552 | N/A | N/A | 2,416 |
| Gross Profit | 23,032 | 16,803 | 21,750 | 1,936 | 64,353 |
| Operating Expenses | 202,796 | 200,973 | 196,121 | 168,691 | 176,275 |
| Operating Income | -179,172 | -183,618 | -178,366 | -166,755 | -111,506 |
| Interest Expense | 34,831 | 33,335 | 30,335 | 26,322 | 24,265 |
| Other Income | 15,241 | 10,922 | 25,670 | -113,101 | 1,401 |
| Pre-tax Income | -198,762 | -206,031 | -183,031 | -306,178 | -134,370 |
| Net Income Continuous | -198,762 | -206,031 | -183,031 | -306,178 | -134,370 |
| Net Income | $-198,762 | $-206,031 | $-183,031 | $-306,178 | $-134,370 |
| EPS Basic Total Ops | -1.50 | -1.67 | -1.51 | -2.55 | -1.12 |
| EPS Basic Continuous Ops | -1.50 | -1.67 | -1.50 | -2.55 | -1.12 |
| EPS Diluted Total Ops | -1.50 | -1.67 | -1.51 | -2.55 | -1.12 |
| EPS Diluted Continuous Ops | -1.50 | -1.67 | -1.50 | -2.55 | -1.12 |
| EPS Diluted Before Non-Recurring Items | -1.50 | -1.67 | -1.50 | -1.54 | -1.12 |
| EBITDA(a) | $-175,541 | $-180,240 | $-175,505 | $-164,076 | $-109,221 |